ABOUT THE PROGRAM
The Radiosurgery Society® (RSS) in collaboration with The American College of Radiation Oncology (ACRO) offers the Distinction in Stereotactic Radiotherapy as an additional accreditation review within the ACRO Accreditation Program. The Distinction in Stereotactic Radiotherapy program is the only SRS/SBRT-dedicated accreditation review by a professional medical society that focuses on practice standards, patient management and medical physics aspects unique to SRS/SBRT treatment. The program was designed by professional peers with extensive experience treating patients with SRS/SBRT, with the aim to identify standards indicative of a quality practice in the field of SRS/SBRT. The Distinction in Stereotactic Radiotherapy program currently focuses on SRS/SBRT treatments within six (6) disease sites: central nervous system (CNS), spine, liver, lung, pancreas and prostate. Centers who wish to apply for Distinction in Stereotactic Radiotherapy need to apply and complete the ACRO Accreditation Program for radiation oncology. ACRO Accreditation is the only US radiation oncology accrediting body to achieve ISO 9001-2015.
Practices must undergo an online medical chart review and a physics review in addition to the normal accreditation process. The medical review portion of the program consists of online chart reviews focused on six disease sites: CNS, spine, liver, lung, pancreas and prostate. Peer reviewers will evaluate cases within their area of expertise. Review consists of a minimum of five (5) charts with a minimum of two (2) charts per disease site. An attempt to represent the patient mix of the practice will be made by the Accreditation staff when selecting charts to be reviewed. The physics survey process was developed by medical physicists with research development backgrounds and clinical expertise in stereotactic radiotherapy using a wide range of delivery technologies. Areas of evaluation include machinery, quality assurance, staff and training, and dose constraints specific to the delivery of SRS and SBRT treatment
FEES AND TERMS
The fee for the Distinction in Stereotactic Radiotherapy is $3,000 per three-year and $4,000 per four-year accreditation term and is valid for the length of the accreditation term. For more information about ACRO Accreditation fees and term lengths, please refer to the ACRO Accreditation Manual.
ACRO Accreditation with Distinction in Stereotactic Radiotherapy is now being offered virtually. Since 2010, ACRO Accreditation has used an online process for reviewing medical charts. Under this innovative and modern system, highly skilled physician reviewers are grouped into teams according to specialization, and work under the oversight of a disease site team leader. The virtual site visit process will include a pre-visit document review, video interviews of key personnel, virtual facility inspection, and detailed reviews of all quality metrics and all elements of the practice's quality assurance (QA) programs. This virtual process will maintain ACRO's and RSS's Accreditation high-quality standards.
The Distinction in Stereotactic Radiotherapy accreditation program was developed by professional experts with extensive experience treating patients with SRS/SBRT. The program currently focuses on six (6) disease sites: CNS, spine, liver, lung, pancreas and prostate. Peer reviewers will evaluate cases within their area of expertise.
|DIRECTORS||DISEASE SITE TEAM LEADERS|
Medical Director, Distinction in Stereotactic Radiotherapy
Central Nervous System (CNS)
Medical Director, ACRO Accreditation
Physics Director, Distinction in Stereotactic Radiotherapy
Physics Director, ACRO Accreditation
If you are interested in applying for ACRO Accreditation with the Distinction in Stereotactic Radiotherapy Accreditation, please contact Valerie Guth at email@example.com or 206-956-3642.